| Discovery of risdiplam (evrysdi) - A medicine for the treatment of spinal muscular atrophy | |||||
|
Thu19 Dec11:00am(30 mins)
|
|
|
Dr Hasane Ratni | ||
| Session : Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA | |||||
| Room: Hall 1B | |||||
| A Fully Automated Data Analysis Workflow for Gene Expression-Based Screening | |||||
|
Thu19 Dec11:30am(30 mins)
|
|
|
Dr Gabriela Nass Kovacs | ||
| Session : Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA | |||||
| Room: Hall 1B | |||||
| mRNA Lightning platform for the discovery of selective small molecule mRNA regulatory drugs | |||||
|
Thu19 Dec12:00pm(30 mins)
|
|
|
Dr Iris Alroy | ||
| Session : Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA | |||||
| Room: Hall 1B | |||||
| Dynamic RNAs and Structure-Guided Small Molecule Drug Discovery | |||||
|
Thu19 Dec02:00pm(30 mins)
|
|
|
Dr Isaac Kimsey |
|
Yang Zheng |
| Session : Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA | |||||
| Room: Hall 1B | |||||
| DNA-Encoded Library Technology for Drug Discovery | |||||
|
Thu19 Dec02:30pm(5 mins)
|
|
|
Assunta Romano | ||
| Session : Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA | |||||
| Room: Hall 1B | |||||
|
Thu19 Dec02:35pm(5 mins)
|
Tecan UK Ltd |
Room: Hall 1B |
| Integrated Drug Discovery: Chemistry and Biology working together to create innovative solutions | |||||
|
Thu19 Dec02:40pm(5 mins)
|
|
|
Dr Catherine Stace | ||
| Session : Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA | |||||
| Room: Hall 1B | |||||
| Small activating RNAs from concept to Phase 2 clinical trial | |||||
|
Thu19 Dec02:45pm(30 mins)
|
|
|
Prof Nagy Habib |
|
Prof Vikash Reebye |
| Session : Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA | |||||
| Room: Hall 1B | |||||
| X-reactivation as an approach to treating Rett Syndrome | |||||
|
Thu19 Dec04:30pm(30 mins)
|
|
|
Prof Jeannie Lee | ||
| Session : Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA | |||||
| Room: Hall 1B | |||||
| High resolution anatomical mapping of gene expression using targeted in situ sequencing | |||||
|
Fri20 Dec11:00am(30 mins)
|
|
|
Dr Mats Nilsson | ||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| Development of an Image-Based HCS-Compatible Method for Endothelial Barrier Function Assessment | |||||
|
Fri20 Dec11:30am(30 mins)
|
|
|
Dr Sun Yung | ||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| Live cell compatible super resolution fluorescence microscopy for 3D imaging | |||||
|
Fri20 Dec12:00pm(30 mins)
|
|
|
Ilaria Testa |
|
Francesca Pennacchietti |
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| Single-cell CRISPR screens in primary human T cells | |||||
|
Fri20 Dec12:30pm(15 mins)
|
|
|
Dr Tilmann Buerckstuemmer | ||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| R&D at the New Speed of Science: Accelerate your R&D Transformation with Benchling | |||||
|
Fri20 Dec12:45pm(5 mins)
|
|
|
Tali Bloom | ||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| Introducing an electronic sensor to measure affinity of intermolecular interactions | |||||
|
Fri20 Dec12:50pm(5 mins)
|
|
|
Dr Sylwia Mankowska | ||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| All Human Drug Research Solutions | |||||
|
Fri20 Dec12:55pm(5 mins)
|
|
|
Mr Paul Gallant | ||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| Chemical Materials Design | |||||
|
Fri20 Dec02:30pm(30 mins)
|
|
|
Dr Ben Slater | ||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| Quantum computing: a new frontier in drug discovery? | |||||
|
Fri20 Dec03:00pm(30 mins)
|
|
|
Sam Genway | ||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| A structural biology community assessment of AlphaFold 2 applications | |||||
|
Fri20 Dec03:40pm(30 mins)
|
|
|
Pedro Beltrao | ||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| MELLODDY: privacy-preserving federated machine learning across pharma partners | |||||
|
Fri20 Dec04:10pm(30 mins)
|
|
|
Dr Hugo Ceulemans | ||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
